Drug Information

General Information
Drug ID
DR00235
Drug Name
Flavopiridol
Synonyms
(-)-cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one; 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE; 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one; Alvocidib [INN]; FLAVO; Flavopiridol; Flavopiridol hydrochloride; HMR-1275; HMR-1275, Alvocidib, L868275, Flavopiridol; L 868275; L-868275; L86-8275
Drug Type
Small molecular drug
Indication Chronic lymphocytic leukemia [ICD11: 2A82.0] Phase 2 [1]
Structure
3D MOL 2D MOL
Formula
C21H20ClNO5
Canonical SMILES
CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O
InChI
InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1
InChIKey
BIIVYFLTOXDAOV-YVEFUNNKSA-N
CAS Number
CAS 131740-09-5
Pharmaceutical Properties Molecular Weight 401.8 Topological Polar Surface Area 90.2
Heavy Atom Count 28 Rotatable Bond Count 2
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 6
XLogP
3.3
PubChem CID
5287969
PubChem SID
104234154 , 11041362 , 113870851 , 124757102 , 125163906 , 126671493 , 126731324 , 127338259 , 127338260 , 127338261 , 127338262 , 127338263 , 131480733 , 134338802 , 135064370 , 135626623 , 136085824 , 136367366 , 136920327 , 137002692 , 142106966 , 14757147 , 152258050 , 160646888 , 160966614 , 162011554 , 164786749 , 172818888 , 172913786 , 175437711 , 176236286 , 177748773 , 178102307 , 180371632 , 39320467 , 46391640 , 46391762 , 46507266 , 49854007 , 50064452 , 51029203 , 53790160 , 57359202 , 606623 , 7886735 , 8035270 , 830646 , 837792 , 85177022 , 99437041
ChEBI ID
ChEBI:47344
TTD Drug ID
D0LF1U
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [3]
References
1 The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. (familyId=5680)
2 The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2. Mol Cancer Ther. 2012 Sep;11(9):2033-44.
3 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.